Debbie Rigby takes a look at the latest in research news
Assessment of the chemical composition of 65 Australian electronic cigarette liquids or e-liquids (sold online and physical stores) revealed one or more potentially harmful chemicals, including benzaldehyde, menthol, trans-cinnamaldehyde, and polycyclic aromatic hydrocarbons. Nicotine or nicotyrine were detected in a small proportion of e-liquids at extremely low concentrations.
Med J Aust, published 15 September 2021.
Understanding the nature and extent of the spirometric overlap between asthma and COPD is critical for tailoring a therapeutic strategy that is based on factors that include medical and family history, signs and symptoms, and a clear interpretation of spirometry data.
Canadian Family Physician 2021;67(9):661-667.
An SGLT2i reduces mortality, heart failure hospitalizations, and improves quality of life when added to other medications for heart failure with reduced ejection fraction—with or without diabetes. Compared with placebo, for every 100 patients treated with SGLT2i for about 1.5 years, about 2 fewer will die, roughly 4 fewer will be hospitalized for heart failure, and roughly 7 more will have improved quality of life.
Canadian Family Physician 2021;67(9):678.
Analysis of claim data of HMRs and RMMRs from 2009 to 2019 shows the negative impact of program rule changes and the under-utilisation of these services. The authors conclude that low levels of HMR and RMMR provision observed do not represent a proactive approach to medicines safety and effectiveness among older Australians.
Int J Environ Res Public Health 2021;18(18):9898.